Walleye Trading’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Walleye Trading’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-56,521	Closed	-$633	–	4862
2017 Q3	$633	Sell	56,521 -45,893	-45%	-$506K	﹤0.01%	2253
2017 Q2	$1.13K	Buy	+102,414	New	+$1.02M	0.01%	1660
2016 Q2	–	Sell	-4,900	Closed	-$54K	–	6012
2016 Q1	$54K	Sell	4,900 -1,271	-21%	-$11.3K	﹤0.01%	3822
2015 Q4	$57K	Buy	6,171 +3,000	+95%	+$25.1K	﹤0.01%	3762
2015 Q3	$22K	Sell	3,171 -2,200	-41%	-$18.8K	﹤0.01%	4038
2015 Q2	$53K	Buy	5,371 +3,700	+221%	+$33.7K	﹤0.01%	3452
2015 Q1	$15K	Buy	1,671 +1,171	+234%	+$9.33K	﹤0.01%	3615
2014 Q4	$4K	Buy	+500	New	+$4.05K	﹤0.01%	4083

Walleye Trading's SCLN Position: Q4 2017 in Review

Walleye Trading sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 56,521 shares — an estimated $633 sold.

Walleye Trading first reported a position in SCLN in Q4 2014 and held it in 8 quarters. The position peaked at $57K in Q4 2015. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Walleye Trading reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Walleye Trading sold 56,521 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $633.
Walleye Trading first reported a position in Sciclone Pharmaceuticals Inc in Q4 2014 and held it in 8 quarters.
Walleye Trading's Sciclone Pharmaceuticals Inc position peaked at $57K in Q4 2015.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Walleye Trading's 13F filing for Q4 2017, filed 14 Feb 2018.